MedPath

Virtus Pharmaceuticals, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

10

FDA:10

Drug Approvals

sildenafil

Approval Date
Jan 30, 2024
FDA

Palonosetron hydrochloride

Approval Date
Oct 31, 2023
FDA

LACOSAMIDE

Approval Date
Apr 13, 2023
FDA

Potassium Chloride

Approval Date
Nov 10, 2022
FDA

PHENDIMETRAZINE TARTRATE

Approval Date
Oct 10, 2022
FDA

NAPROXEN

Approval Date
Jul 14, 2022
FDA

Olanzapine

Approval Date
May 31, 2022
FDA

Ketorolac Tromethamine

Approval Date
May 17, 2022
FDA

Levorphanol Tartrate

Approval Date
Sep 25, 2020
FDA

PHENDIMETRAZINE TARTRATE

Approval Date
Apr 2, 2019
FDA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy